Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
262 studies found for:    "SARS"
Show Display Options
Rank Status Study
1 Completed Investigating Severe Acute Respiratory Syndrome (SARS)
Condition: SARS Virus
Intervention:
2 Withdrawn Phase I Dose Escalation SARS-CoV Recombinant S Protein, With and Without Adjuvant, Vaccine Study
Condition: SARS
Interventions: Drug: Aluminum hydroxide adjuvant (Alhydrogel®);   Other: Phosphate buffered saline Placebo;   Biological: Recombinant S protein SARS vaccine
3 Completed Collection of Convalescent SARS Plasma by Apheresis
Conditions: Severe Acute Respiratory Syndrome;   SARS
Intervention:
4 Withdrawn SARS Survivor Evaluations
Condition: Coronavirus (SARS-CoV)
Intervention:
5 Withdrawn SARS Coronavirus Vaccine (SARS-CoV)
Condition: Coronavirus (SARS-CoV)
Interventions: Drug: Aluminum hydroxide;   Drug: Placebo;   Biological: SARS-CoV
6 Completed Dynamic Profiles of Cytokine/Chemokine in Severe Acute Respiratory Syndrome
Condition: SARS
Intervention:
7 Withdrawn Evaluation and Treatment of Severe Acute Respiratory Syndrome (SARS)
Condition: Severe Acute Respiratory Syndrome
Intervention:
8 Recruiting Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR)
Condition: Seasonal Allergic Rhinitis (SAR)
Interventions: Drug: GSP 301 NS;   Drug: GOM-NS;   Drug: GMM-2 NS;   Drug: GSP 301 placebo NS
9 Unknown  A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome
Condition: Severe Acute Respiratory Syndrome
Intervention: Drug: Lopinavir / Ritonavir plus Ribavirin
10 Completed Study of Alferon® LDO (Low Dose Oral) in Normal Volunteers
Condition: Severe Acute Respiratory Syndrome
Intervention: Drug: Alferon LDO
11 Completed Phase I Study of a Vaccine for Severe Acute Respiratory Syndrome (SARS)
Condition: Healthy
Interventions: Procedure: Blood Test;   Procedure: Urine Test;   Procedure: Physical Exam;   Drug: Vaccine;   Drug: VRC-SRSDNA015-00-VP
12 Completed Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)
Conditions: Allergic Rhinitis;   Hay Fever;   SAR;   Rhinitis, Allergic, Seasonal
Interventions: Drug: Cetirizine;   Drug: Loratadine;   Other: Placebo
13 Completed Contamination During Removal of Two Different Personal Protective Systems
Condition: Severe Acute Respiratory Syndrome
Intervention: Procedure: Powered Air purifying respirator
14 Completed Clinical Study of SARS in Children
Condition: Epidemiology
Intervention:
15 Completed Seroprevalence of MERS-CoV IgG in Healthcare Workers
Condition: Coronavirus Infections
Intervention:
16 Completed Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602)
Condition: Rhinitis, Allergic, Seasonal
Interventions: Drug: Ciclesonide HFA;   Drug: Placebo
17 Completed A 5-way Treatment Period Trial of Single Doses of Intranasal GSK256066 in Patients With Rhinitis
Conditions: Rhinitis, Allergic, Seasonal;   Seasonal Allergic Rhinitis;   SAR
Intervention: Drug: GSK256066
18 Active, not recruiting Trial of Pimasertib With SAR245409 or Placebo in Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Pimasertib once daily;   Drug: Pimasertib placebo;   Drug: SAR245409 placebo;   Drug: SAR245409;   Drug: Pimasertib twice daily
19 Not yet recruiting Trial of Isatuximab (SAR650984) in Patients With Intermediate and High Risk Smoldering Multiple Myeloma
Condition: Myeloma
Interventions: Drug: Isatuximab;   Behavioral: Phone Calls;   Drug: Diphenhydramine;   Drug: Ranitidine;   Drug: Methylprednisolone
20 Terminated SAR3419 in Acute Lymphoblastic Leukemia
Condition: Acute Lymphocytic Leukaemia
Intervention: Drug: SAR3419

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.